The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

“Cancer doesn’t respect borders, so why should we?” Watch this TEDx talk on cancer inequalities

November 27, 2019

In May this year, Professor Mark Lawler, a member of the EACR and IACR, gave a thought-provoking talk at TEDxQueensUniversityBelfast titled “Tackling Cancer Inequalities: The Time to Act is NOW!” He discussed being part of a collaboration of around 60 partners of cancer patients, patient advocates and healthcare professionals that helped to introduce the European Cancer Patient’s Bill of Rights on World Cancer Day in 2014.

There are three main principles of the Bill of Rights:

  • It is the right of every European citizen to receive the most accurate information and to be proactively involved in his/her care.
  • The right of every European citizen to optimal and timely access to a diagnosis and to appropriate specialised care, underpinned by research and innovation.
  • The right of every European citizen to receive care in health systems that ensure the best possible cancer prevention, the earliest possible diagnosis of their cancer, improved outcomes, patient rehabilitation, best quality of life and affordable health care.

Here are some key points from Professor Lawler’s passionate talk:

There are huge disparities within Europe with regards to survival rates, diagnosis, access to treatment and research & innovation.

  • In Poland, the lung cancer mortality rate is 83%, whereas the European average is 56.4%.
  • In Romania, the cervical cancer mortality rate is 14.2%, whereas the European average is 3.7%.
  • The survival rate is up to 40% higher in Western Europe compared to Eastern Europe.
  • This isn’t exclusive to Eastern Europe – in Northern Ireland, there was a ‘postcode lottery’ which saw some people in the UK miss out on access to innovative drugs.

“Cancer doesn’t respect borders, so why should we?”

  • The Bill of Rights has been signed by 25 different European countries, with 60 partners involved.
  • Research and innovation across borders: there are challenges with early diagnosis in the UK and Denmark. Danish research found ways to combat this, and this was shared with the UK
  • 87% of countries have a National Cancer Control Plan, which drops to 54% in Central & Eastern Europe. An aim of raising awareness and talking to politicians to change this statistic.

“The end of cancer treatment does not signal the end of cancer care”

  • Raising awareness that despite being cured, there are still the psycho-social, mental, emotional and financial affects of cancer that are often overlooked.
  • There are now more and more conferences and meetings catering for cancer survivors and cancer patients.
  • The Bill of Rights challenges inequalities that patients regularly experience.

70:35 vision – the aim that an average of a 70% long-term survival rate from cancer is achieved by 2035.

  • By working together and sharing best practice, this should be achievable.
  • Everyone can be involved! For example, Cancer Focus Northern Ireland helped to galvanise 30,000 signatures in an equal access campaign to demand improved access to innovative drugs and medicines.
  • Research and innovation is important: patients are more likely to have a better outcome if they are treated in a research hospital.
  • The Bill of Rights is a catalyst for change and a tool of empowerment for cancer patients.
Tags: collaborationEACR Membersnews summaryvideo

Related Posts

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities

April 20, 2026

The EACR, AACR, and The Mark Foundation for Cancer Research recently teamed up to offer a number of travel grants to help EACR or AACR members...

VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter

VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter

April 22, 2026

https://www.youtube.com/watch?v=KdMqmIIgNYo Click above to watch On 9 April 2026, the EACR hosted a free webinar bringing together leading experts to explore the Cancer Genome Interpreter (CGI)...

Patients Shaping Cancer Research – Episode 31 of The Cancer Researcher Podcast

Patients Shaping Cancer Research – Episode 31 of The Cancer Researcher Podcast

April 13, 2026

What does it take to bridge the gap between researchers and patients? In this episode, scientists, oncologists, and patient advocates from Canada, the United States, and...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

RECENT POSTS

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities
Community

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities

April 20, 2026
VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter
Features

VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter

April 22, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR